Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Diagnostic Pathology|September 4, 2019
Concordance among four commercially available, validated programmed cell death ligand-1 assays in urothelial carcinomaMagdalena Zajac, Marietta Scott, Marianne Ratcliffe, et al.
Molecular & Cellular Proteomics : MCP|June 25, 2015
Evaluation of Protein Profiles From Treated Xenograft Tumor Models Identifies an Antibody Panel for Formalin-fixed and Paraffin-embedded (FFPE) Tissue Analysis by Reverse Phase Protein Arrays (RPPA)Sabine Bader, Magdalena Zajac, Thomas Friess, et al.
Human Vaccines & Immunotherapeutics|November 29, 2022
Monitoring of molecular profiling of allergen-antibody responses in HDM-immunotherapy patientsMarita Nittner-Marszalska, Agnieszka Kopeć, Aleksandra Foks-Ciekalska, et al.
Pancreas|January 31, 2016
Profiling of cMET and HER Family Receptor Expression in Pancreatic Ductal Adenocarcinomas and Corresponding Lymph Node Metastasis to Assess Relevant Pathways for Targeted Therapies: Looking at the Soil Before Planting the SeedAlexander Muckenhuber, Galina Babitzki, Marlene Thomas, et al.
Plos One|April 28, 2020
Optimal PD-L1-high cutoff for association with overall survival in patients with urothelial cancer treated with durvalumab monotherapyMagdalena Zajac, Jiabu Ye, Pralay Mukhopadhyay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2007
Identification of a proliferation signature related to survival in nodal peripheral T-cell lymphomasMarta Cuadros, Sandeep S Dave, Elaine S Jaffe, et al.
Blood|July 20, 2007
Expression of CYP3A4 as a predictor of response to chemotherapy in peripheral T-cell lymphomasCristina Rodríguez-Antona, Susanna Leskelä, Magdalena Zajac, et al.
Cancer Investigation|June 5, 2023
The Utility of ctDNA in Lung Cancer Clinical Research and Practice: A Systematic Review and Meta-Analysis of Clinical StudiesXuezheng Sun, Page Abrahamson, Nicholas Ballew, et al.
Therapeutic Advances in Hematology|September 18, 2024
Phase I/II study of the clinical activity and safety of GSK3326595 in patients with myeloid neoplasmsJustin Watts, Mark D Minden, Kimo Bachiashvili, et al.
British Journal of Cancer|August 17, 2016
Acute tumour response to a bispecific Ang-2-VEGF-A antibody: insights from multiparametric MRI and gene expression profilingLauren C J Baker, Jessica K R Boult, Markus Thomas, et al.
Pageof 3